Insitro acquires CombinAble.AI
Insitro agreed to acquire CombinAble.AI. Reported deal value: Undisclosed. Status: Completed. Sector: Biotech. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-01-22. Figures and status may change as filings and press coverage update.
Mati Gill, CEO of AION Labs Photo courtesy of Elad Malka SAN FRANCISCO – Mati Gill, CEO of Israel-based AION Labs, sat down with MobiHealthNews outside the JPM Healthcare Conference to discuss the purchase of AION portfolio company CombinAble.AI by drug discovery and development company Insitro , which marked a rapid and strategic outcome for a venture built from scratch within AION Labs
Deal timeline
This transaction is classified in Biotech. Figures and status may change as sources update.